Nuveen’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-791,221
| Closed | -$15.7M | – | 3376 |
|
|
2023
Q1 | $15.7M | Sell |
791,221
-44,391
| -5% | -$767K | 0.01% | 1199 |
|
|
2022
Q4 | $11.4M | Buy |
835,612
+37,470
| +5% | +$522K | ﹤0.01% | 1402 |
|
|
2022
Q3 | $11.1M | Sell |
798,142
-6,246
| -0.8% | -$92.8K | ﹤0.01% | 1415 |
|
|
2022
Q2 | $11.6M | Buy |
804,388
+266,171
| +49% | +$4.62M | ﹤0.01% | 1410 |
|
|
2022
Q1 | $11M | Buy |
538,217
+413,968
| +333% | +$8.04M | ﹤0.01% | 1579 |
|
|
2021
Q4 | $2.35M | Sell |
124,249
-6,131
| -5% | -$164K | ﹤0.01% | 2493 |
|
|
2021
Q3 | $4.77M | Sell |
130,380
-5,750
| -4% | -$215K | ﹤0.01% | 2241 |
|
|
2021
Q2 | $5.81M | Sell |
136,130
-19,955
| -13% | -$780K | ﹤0.01% | 2174 |
|
|
2021
Q1 | $5.98M | Sell |
156,085
-53,756
| -26% | -$2.29M | ﹤0.01% | 2089 |
|
|
2020
Q4 | $9.18M | Sell |
209,841
-25,268
| -11% | -$951K | ﹤0.01% | 1764 |
|
|
2020
Q3 | $9.25M | Buy |
235,109
+35,795
| +18% | +$1.16M | ﹤0.01% | 1572 |
|
|
2020
Q2 | $6.29M | Sell |
199,314
-78,727
| -28% | -$2.94M | ﹤0.01% | 1771 |
|
|
2020
Q1 | $9.79M | Buy |
278,041
+76,811
| +38% | +$3.24M | ﹤0.01% | 1302 |
|
|
2019
Q4 | $9.78M | Buy |
201,230
+4,804
| +2% | +$219K | ﹤0.01% | 1602 |
|
|
2019
Q3 | $9.33M | Sell |
196,426
-114,421
| -37% | -$5.38M | ﹤0.01% | 1617 |
|
|
2019
Q2 | $13.3M | Buy |
+310,847
| New | +$12.1M | 0.01% | 1423 |
|
|
2018
Q1 | – | Sell |
-41,395
| Closed | -$981K | – | 1155 |
|
|
2017
Q4 | $981K | Sell |
41,395
-5,540
| -12% | -$140K | 0.01% | 749 |
|
|
2017
Q3 | $1.32M | Sell |
46,935
-5,197
| -10% | -$158K | 0.01% | 696 |
|
|
2017
Q2 | $1.68M | Buy |
52,132
+2,410
| +5% | +$73.4K | 0.01% | 644 |
|
|
2017
Q1 | $1.41M | Buy |
+49,722
| New | +$1.32M | 0.01% | 827 |
|
Other funds holding CSII
Nuveen's CSII Position: Q2 2023 in Review
Nuveen sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 791,221 shares — an estimated $15.7M sold.
Nuveen first reported a position in CSII in Q1 2017 and held it in 20 quarters. The position peaked at $15.7M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Nuveen reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Nuveen sold 791,221 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $15.7M.
- Nuveen first reported a position in Cardiovascular Systems, Inc. in Q1 2017 and held it in 20 quarters.
- Nuveen's Cardiovascular Systems, Inc. position peaked at $15.7M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.